|
|
Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.
Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.
If all the neurons in the human body were lined up, they would stretch more than 600 miles.
More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.
On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.